{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:51:55Z","timestamp":1790009515947,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,10]]},"DOI":"10.7759\/cureus.87649","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:35:21Z","timestamp":1752136521000},"source":"Crossref","is-referenced-by-count":1,"title":["Carvedilol vs. Metoprolol Effectiveness in Patients With Left Ventricular Assist Devices: A TriNetX Analysis"],"prefix":"10.7759","author":[{"given":"Karldon I","family":"Nwaezeapu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godbless","family":"Ajenaghughrure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekow","family":"Essien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smith","family":"Frimpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuemeka  C","family":"Aghasili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"God-dowell O","family":"Odukudu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash B","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ndakotsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraneh","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics - 2020 update: a report from the American Heart Association","volume":"141","author":"Virani SS","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, et al.. Heart disease and stroke statistics - 2020 update: a report from the American Heart Association. Circulation. 2020, 141:139-596. 10.1161\/CIR.0000000000000757","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900486","article-title":"A fully magnetically levitated left ventricular assist device - final report","volume":"380","author":"Mehra MR","year":"2019","unstructured":"Mehra MR, Uriel N, Naka Y, et al.. A fully magnetically levitated left ventricular assist device - final report. N Engl J Med. 2019, 380:1618-27. 10.1056\/NEJMoa1900486","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.07.005","article-title":"Eighth Annual INTERMACS Report: special focus on framing the impact of adverse events","volume":"36","author":"Kirklin JK","year":"2017","unstructured":"Kirklin JK, Pagani FD, Kormos RL, et al.. Eighth Annual INTERMACS Report: special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017, 36:1080-6. 10.1016\/j.healun.2017.07.005","journal-title":"J Heart Lung Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.11.013","article-title":"The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships","volume":"38","author":"Kormos RL","year":"2019","unstructured":"Kormos RL, Cowger J, Pagani FD, et al.. The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019, 38:114-26. 10.1016\/j.healun.2018.11.013","journal-title":"J Heart Lung Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy CW","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017, 136:137-61. 10.1161\/CIR.0000000000000509","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski P","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al.. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016, 37:2129-200. 10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022, 145:895-1032. 10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.11.031","article-title":"Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol)","volume":"111","author":"DiNicolantonio JJ","year":"2013","unstructured":"DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O'Keefe JH. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). Am J Cardiol. 2013, 111:765-9. 10.1016\/j.amjcard.2012.11.031","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter MS","year":"2009","unstructured":"Slaughter MS, Rogers JG, Milano CA, et al.. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009, 361:2241-51. 10.1056\/NEJMoa0909938","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson PA","year":"2003","unstructured":"Poole-Wilson PA, Swedberg K, Cleland JG, et al.. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003, 362:7-13. 10.1016\/S0140-6736(03)13800-7","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.3258","article-title":"Association of treatment with carvedilol vs. metoprolol succinate and mortality in patients with heart failure","volume":"174","author":"Pasternak B","year":"2014","unstructured":"Pasternak B, Svanstr\u00f6m H, Melbye M, Hviid A. Association of treatment with carvedilol vs. metoprolol succinate and mortality in patients with heart failure. JAMA Intern Med. 2014, 174:1597-604. 10.1001\/jamainternmed.2014.3258","journal-title":"JAMA Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.07.990","article-title":"Obstructive sleep apnea and atrial fibrillation: is the link real?","volume":"64","author":"Malhotra A","year":"2014","unstructured":"Malhotra A, Neilan TG, Sarmiento K. Obstructive sleep apnea and atrial fibrillation: is the link real?. J Am Coll Cardiol. 2014, 64:2024-5. 10.1016\/j.jacc.2014.07.990","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.04.020","article-title":"Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?","volume":"61","author":"Garan AR","year":"2013","unstructured":"Garan AR, Yuzefpolskaya M, Colombo PC, et al.. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?. J Am Coll Cardiol. 2013, 61:2542-50. 10.1016\/j.jacc.2013.04.020","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin PC","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011, 46:399-424. 10.1080\/00273171.2011.568786","journal-title":"Multivariate Behav Res"},{"key":"ref15","article-title":"Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial","volume":"3","author":"Kveiborg B","year":"2007","unstructured":"Kveiborg B, Major-Petersen A, Christiansen B, Torp-Pedersen C. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial. Vasc Health Risk Manag. 2007, 3:31-7.","journal-title":"Vasc Health Risk Manag"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.020","article-title":"Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy)","volume":"61","author":"Ruwald MH","year":"2013","unstructured":"Ruwald MH, Ruwald AC, Jons C, Alexis J, McNitt S, Zareba W, Moss AJ. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy). J Am Coll Cardiol. 2013, 61:1518-26. 10.1016\/j.jacc.2013.01.020","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(00)00082-1","article-title":"Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability","volume":"47","author":"Cargnoni A","year":"2000","unstructured":"Cargnoni A, Ceconi C, Bernocchi P, Boraso A, Parrinello G, Curello S, Ferrari R. Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. Cardiovasc Res. 2000, 47:556-66. 10.1016\/S0008-6363(00)00082-1","journal-title":"Cardiovasc Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.6219","article-title":"Oxidative stress, DNA damage and repair in heart failure patients after implantation of continuous flow left ventricular assist devices","volume":"10","author":"Mondal NK","year":"2013","unstructured":"Mondal NK, Sorensen E, Hiivala N, Feller E, Griffith B, Wu ZJ. Oxidative stress, DNA damage and repair in heart failure patients after implantation of continuous flow left ventricular assist devices. Int J Med Sci. 2013, 10:883-93. 10.7150\/ijms.6219","journal-title":"Int J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000041","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"January CT","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, et al.. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2014, 130:199-267. 10.1161\/CIR.0000000000000041","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.003863","article-title":"Early right ventricular assist device use in patients undergoing continuous-flow left ventricular assist device implantation: incidence and risk factors from the interagency registry for mechanically assisted circulatory support","volume":"10","author":"Kiernan MS","year":"2017","unstructured":"Kiernan MS, Grandin EW, Brinkley M Jr, et al.. Early right ventricular assist device use in patients undergoing continuous-flow left ventricular assist device implantation: incidence and risk factors from the interagency registry for mechanically assisted circulatory support. Circ Heart Fail. 2017, 10:10.1161\/CIRCHEARTFAILURE.117.003863","journal-title":"Circ Heart Fail"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.07.152","article-title":"Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling","volume":"132","author":"Jozwiak J","year":"2009","unstructured":"Jozwiak J, Sahin M, Jozwiak S, Kotulska K, Ploski R, Szperl M, Wlodarski PK. Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling. Int J Cardiol. 2009, 132:145-7. 10.1016\/j.ijcard.2007.07.152","journal-title":"Int J Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3280127948","article-title":"Antioxidant activity of carvedilol in cardiovascular disease","volume":"25","author":"Dandona P","year":"2007","unstructured":"Dandona P, Ghanim H, Brooks DP. Antioxidant activity of carvedilol in cardiovascular disease. J Hypertens. 2007, 25:731-41. 10.1097\/HJH.0b013e3280127948","journal-title":"J Hypertens"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-11-1-28","article-title":"A review of infections in patients with left ventricular assist devices: prevention, diagnosis and management","volume":"11","author":"Trachtenberg BH","year":"2015","unstructured":"Trachtenberg BH, Cordero-Reyes A, Elias B, Loebe M. A review of infections in patients with left ventricular assist devices: prevention, diagnosis and management. Methodist Debakey Cardiovasc J. 2015, 11:28-32. 10.14797\/mdcj-11-1-28","journal-title":"Methodist Debakey Cardiovasc J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/366887-carvedilol-vs-metoprolol-effectiveness-in-patients-with-left-ventricular-assist-devices-a-trinetx-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:35:22Z","timestamp":1752136522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/366887-carvedilol-vs-metoprolol-effectiveness-in-patients-with-left-ventricular-assist-devices-a-trinetx-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.87649","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}